UCB (Euronext Brussels: UCB) and Biogen Idec (NASDAQ: BIIB) today announced a global collaboration to jointly develop and commercialize CDP323 for the treatment of relapsing-remitting multiple sclerosis (MS) and other potential indications. CDP323 is an orally active small molecule alpha4-integrin inhibitor expected to enter Phase II clinical trials next year.
Breastfed babies are more intelligent because a higher percentage of highly educated mothers tend to breastfeed, say researchers from the Medical Research Council (UK) and the University of Edinburgh. A higher percentage of breastfed babies are brought up in a mentally stimulating environment. You can read about this study in the British Medical Journal.
The developmental oral therapy FTY720 (fingolimod) has demonstrated sustained benefits over two years in patients suffering from relapsing multiple sclerosis (MS), indicating that it could provide an important new option for treating this disabling neurological disease estimated to affect more than 2.5 million people worldwide.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. today announced that ceftobiprole, a novel cephalosporin(1) antibiotic in Phase III clinical trials, was found to be active against complicated skin infections caused by common, potentially deadly bacteria, including MRSA. These data were from two poster presentations given at the 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). These data also were highlighted by ICAAC. Ceftobiprole is being co-developed with Basilea Pharmaceutica, Ltd. through an exclusive worldwide collaboration.
UAB (University of Alabama at Birmingham) researchers are investigating whether a common but usually harmless virus can be used to treat a particularly devastating type of brain tumor called malignant glioma. The virus — respiratory enteric orphan virus, or reovirus — inhabits the lungs and intestines of humans. By adulthood, most humans have been exposed to it but demonstrate no illness or effects from the infection.
Preliminary findings also showed a link to poorer lung function. Children of mothers who take in too little vitamin E during pregnancy may be at higher risk for asthma by age five, a new study suggests.
They typically don’t survive as long as male patients, study finds. Women on long-term oxygen therapy for chronic obstructive pulmonary disease (COPD) are 54 percent more likely to die than male patients, a new study shows.
Every day we are exposed to external toxins from our environment and internal toxins produced as the byproduct of our digestive and metabolic processes. Toxic and unwanted inorgranic chemicals are found in our foods, water and air in the form of fertilizers, pesticides, heavy metals and other pollutants.
Kids whose lungs react sensitively to cold air may be at increased risk for asthma later in life, new research shows.
1. – Numbness and tingling in all parts.